Approval · Notice of Compliance 18831 · 2017
FORADIL: Notice of Compliance 18831
Issued January 4, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18831
- Date
- January 4, 2017
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Add the divice manufacturer name onto the foradil folding box and to update the foradil aerolizer inhaler artwork
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FORADIL | Not yet assigned | — |
Medicinal ingredients
- FORMOTEROL FUMARATE 12 MCG per CAP